Document:

Exhibit
4.6

 

CANCER
CAPITAL CORP.

DESCRIPTION
OF SECURITIES

 

Authorized Capital
Stock

The Company is authorized to issue
20,000,000 shares of common stock, par value $.001. All shares of common stock have equal rights and privileges with respect to
voting, liquidation and dividend rights. Each share of common stock entitles the holder thereof (i) to one non-cumulative vote
for each share held of record on all matters submitted to a vote of the stockholders, (ii) to participate equally and to receive
any and all such dividends as may be declared by the Board of Directors out of funds legally available; and (iii) to participate
pro rata in any distribution of assets available for distribution upon liquidation of the Company. Our stockholders have no preemptive
rights to acquire additional shares of common stock or any other securities.

 

Voting Rights

 

A majority of our outstanding shares,
represented by person or by proxy, shall constitute a quorum at each meeting of the shareholders. If a quorum exists, action on
a matter, other than the election of directors, is approved if the votes cast favoring the action exceed the votes cast opposing
the action.

 

Directors are elected by a plurality
of the votes cast by the shares entitled to vote in the election at a meeting at which a quorum is present.

 

Change of Control Limitations

 

Our Articles of Incorporation provide
that no sale, conveyance, transfer, exchange or other disposition of all or substantially all of the property and assets of the
Company shall be made unless approved by the vote or written consent of the stockholders entitled to exercise two-thirds (2/3)
of the voting power of the Company.

 

Other Securities

As of the date of this
filing, we do not have any debt securities, warrants or options outstanding.

Transfer Agent

 

Our transfer agent is Standard Registrar
& Stock Transfer Co., Inc. located in Salt Lake City, Utah.SUMMARY SHEET OF EXECUTIVE CASH COMPENSATION

 Exhibit 10.1 

SUMMARY SHEET OF EXECUTIVE CASH COMPENSATION 

This Summary Sheet contains the 2019 and 2020 annual base salaries and target percentages under the Key Officers Incentive Plan (“KOIP”)
adopted by the Board’s Compensation Committee (the “Committee”) on November 5, 2018 and November 4, 2019, respectively, and the 2019 individual performance goals (“IPGs”) adopted by the Committee on
November 5, 2018 for the Company’s principal executive officer, principal financial officer and other named executive officers. This Summary Sheet also contains the 2020 annual base salaries that were reduced by the Committee on
April 9, 2020, to reflect the adjusted rate for bi-weekly pay periods effective April 12, 2020 in response to the economic downturn and uncertainty caused by the
COVID-19 pandemic. However, the Committee provided that the salary reductions are not effective with respect to calculating any benefit under any severance benefit agreement with executive officers. 

 

													
	 Named Executive Officers
	  	2019 Base
Salary	 	  	Initial
2020 Base
Salary	 	  	Reduced
2020 Base
Salary	 
	 Karl G. Glassman, Chairman & CEO
	  	$	1,225,000	 	  	$	1,225,000	 	  	$	612,500	 
	 J. Mitchell Dolloff, President & COO, President – Bedding Products
	  	$	600,000	 	  	$	700,000	 	  	$	350,000	 
	 Jeffrey L. Tate, EVP &
CFO1
	  	$	550,000	 	  	$	570,000	 	  	$	285,000	 
	 Scott S. Douglas, SVP – General Counsel & Secretary 
	  	$	420,000	 	  	$	450,000	 	  	$	225,000	 
	 Perry E. Davis, Former EVP, President – Residential Products & Industrial
Products (SVP – Operations, 1/1/2020 through 2/7/2020)2
	  	$	530,000	 	  	$	530,000	 	  	 	N/A	 
	 Matthew C. Flanigan, Former EVP &
CFO3
	  	$	572,000	 	  	 	N/A	 	  	 	N/A	 

  

	1 	 As previously reported, on August 6, 2019, Mr. Tate was appointed Executive Vice President and Chief
Financial Officer, effective September 3, 2019 (“Start Date”). In addition to his base salary, Mr. Tate received a one-time cash sign-on bonus
of $250,000 upon the Start Date, which must be repaid if he terminates his employment without “Good Reason,” or is terminated for “Cause” within the first year of employment, and half of which must be repaid, under the same
circumstances, within the second year of employment. Also, if Mr. Tate is terminated, other than for “Cause,” death or disability, or if he terminates his employment for “Good Reason,” then the Company must pay Mr. Tate
(a) 12 months of base salary if the termination occurs within the first 12 months after the Start Date, or 6 months of base salary if the termination occurs between 12 and 24 months after the Start Date; (b) a
pro-rata incentive award under the KOIP for the year in which the termination occurred; and (c) a lump sum payment equal to 18 months of COBRA medical coverage. The Company must also provide reasonable
and customary outplacement services for the shorter of 12 months from termination or the date Mr. Tate accepts another position. For definitions of “Good Reason” and “Cause,” reference is made to the Separation Agreement
between Mr. Tate and the Company, dated August 6, 2019, filed August 6, 2019 as Exhibit 10.12 to the Company’s Form 8-K. The definition of “Good Reason” does include the reduction
of Mr. Tate’s base salary as in effect on his Start Date. On April 9, 2020, in conjunction with the Committee’s reduction of his base salary, Mr. Tate waived his right to terminate employment for Good Reason and receive
termination benefits under the Separation Agreement by the Limited Waiver – Separation Agreement attached as Exhibit 10.2 to the Company’s Form 8-K filed April 14, 2020. 

	2 	 As previously reported, Mr. Davis notified the Company of his decision to retire from the Company
effective February 7, 2020. He served in a non-executive officer role as Senior Vice President – Operations, beginning January 1, 2020 until his retirement. 

	3 	 As previously reported, on September 3, 2019, Mr. Flanigan retired as Chief Financial Officer and
began serving in a non-executive officer position. Also, as previously reported, on September 25, 2019, he notified the Company of his decision to retire from the Company effective December 31, 2019.
He retired from the Company on that date. 

 Except as noted below, the named executive officers will be eligible to receive an annual
cash incentive under the 2020 KOIP (filed February 19, 2020 as Exhibit 10.1 to the Company’s Form 8-K) in accordance with the 2020 KOIP Award Formula, adopted on February 18, 2020 and attached
as Exhibit 10.4 to the Company’s Form 8-K filed February 19, 2020. Each executive’s cash award is to be calculated by multiplying his annual base salary at the end of the KOIP plan year by a
percentage set by the Committee (the “Target Percentage”), then applying the award formula adopted by the Committee for that year. The Award Formula in 2019 consisted of three performance criteria: Return on Capital Employed
(“ROCE”) (60% Relative Weight), Cash Flow, or Free Cash Flow for Mr. Davis (20% Relative Weight) and individual performance goals (“IPGs”) (20% Relative Weight). The performance criteria for 2020 does not
include IPGs but does include ROCE (60% Relative Weight) and Cash Flow (40% Relative Weight). As previously reported, the Target Percentages in 2019, and as adopted for 2020 by the Committee on November 4, 2019, for the principal executive
officer, principal financial officer, and other named executive officers are shown in the following table. 
  

									
	 Named Executive Officers
	  	2019 KOIP
Target
Percentage	 	 	2020 KOIP
Target
Percentage	 
	 Karl G. Glassman, Chairman & CEO
	  	 	120	% 	 	 	120	% 
	 J. Mitchell Dolloff, President & COO, President – Bedding Products
	  	 	100	% 	 	 	100	% 
	 Jeffrey L. Tate, EVP &
CFO1
	  	 	80	% 	 	 	80	% 
	 Scott S. Douglas, SVP – General Counsel & Secretary 
	  	 	60	% 	 	 	60	% 
	 Perry E. Davis, Former EVP, President – Residential Products & Industrial
Products (SVP – Operations, 1/1/2020 through 2/7/2020)2 
	  	 	80	% 	 	 	N/A	 
	 Matthew C. Flanigan, Former EVP &
CFO3
	  	 	80	% 	 	 	N/A	 

  

	1 	 As previously reported, on August 6, 2019, Mr. Tate was appointed Executive Vice President and Chief
Financial Officer, effective September 3, 2019. As such, his 2019 KOIP Target Percentage was set on August 6, 2019. Also, in 2019, Mr. Tate’s KOIP Award Formula was not based on the 2019 Award Formula (60% ROCE, 20% Cash Flow and
20% IPGs), but rather was based on 70% ROCE and 30% Cash Flow of the Company, prorated for the number of days employed in 2019. 

	2 	 As previously reported, Mr. Davis notified the Company of his decision to retire from the Company,
effective February 7, 2020. He served in a non-executive officer role as Senior Vice President – Operations, beginning January 1, 2020 until his retirement. As such, he will not receive a KOIP
incentive for 2020. 

	3 	 As previously reported, on September 3, 2019, Mr. Flanigan retired as Chief Financial Officer and
began serving in a non-executive officer position. On September 25, 2019, he notified the Company of his decision to retire from the Company effective December 31, 2019. As such, Mr. Flanigan
will not receive a KOIP incentive for 2020. Mr. Flanigan’s 2019 KOIP incentive was not based on the 2019 Award Formula (60% ROCE, 20% Cash Flow, and 20% IPGs), but rather was based on 70% ROCE and 30% Cash Flow of the Company.

  
 2 

 Individual Performance Goals. On November 5, 2018, the Committee adopted IPGs for our
named executive officers for 2019. Except as noted below, the 2019 KOIP Award Formula, provided that 20% of each executive’s cash award under our KOIP will be based on the achievement of IPGs. The 2020 KOIP Award Formula does not include IPGs.
The IPGs for our named executive officers in 2019 were: 
  

					
	 Named Executive Officers
	  	 2019 IPGs
	  	 2020 IPGs

	 Karl G. Glassman, Chairman & CEO
	  	Acquisition integration, succession planning, CFO onboarding and communications strategy	  	N/A
	 J. Mitchell Dolloff, President & COO, President – Bedding
Products
	  	Implementation of growth strategy and succession planning	  	N/A
	 Jeffrey L. Tate, EVP &
CFO1
	  	N/A	  	N/A
	 Scott S. Douglas, SVP – General Counsel & Secretary
	  	Implementation of growth strategy, succession planning and operational initiatives	  	N/A
	 Perry E. Davis, Former EVP, President – Residential Products & Industrial
Products (SVP – Operations, 1/1/2020 through 2/7/2020)2
	  	Acquisition integration and succession planning	  	N/A
	 Matthew C. Flanigan, Former EVP &
CFO3
	  	N/A	  	N/A

  

	1 	 As previously reported, on August 6, 2019, Mr. Tate was appointed Executive Vice President and Chief
Financial Officer, effective September 3, 2019. As such, Mr. Tate was not assigned IPGs for 2019. 

	2 	 As previously reported, Mr. Davis notified the Company of his decision to retire from the Company,
effective February 7, 2020. He served in a non-executive officer role as Senior Vice President – Operations, beginning January 1, 2020 until his retirement. 

	3 	 As previously reported, on September 3, 2019, Mr. Flanigan retired as Chief Financial Officer and
began serving in a non-executive officer position. On September 25, 2019, he notified the Company of his decision to retire from the Company effective December 31, 2019. Mr. Flanigan was not
assigned IPGs for 2019. 

 The achievement of the IPGs was measured by the following schedule. 

 

					
	 Individual Performance Goals

Payout Schedule
	 
	 Achievement
	  	Payout	 
	 1 – Did not achieve goal
	  	 	0	% 
	 2 – Partially achieved goal
	  	 	50	% 
	 3 – Substantially achieved goal
	  	 	75	% 
	 4 – Fully achieved goal
	  	 	100	% 
	 5 – Significantly exceeded goal
	  	 	up to 150	% 

  
 3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00307-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00307-of-00352.parquet"}]]